Hematology-Oncology Therapy is a well-organized text book that covers almost 500 treatment regimens for many malignant diseases in a stringent, concise, and logical way. For each disease, epidemiology, pathology, work-up, staging, survival, caveats and distinct regimens are discussed and original citations provided. At almost 900 pages, Hematology-Oncology Therapy gives an overview of numerous chemotherapy regimens in hematology-oncology and also includes a chapter on supportive therapy that is provided in a script-like form. Most authors are affiliated at the NIH, and accordingly the selection of regimens included follow the local recommendations, although an effort is made to include the most frequently applied schemata.
Hematology-Oncology Therapy is organized alphabetically according to malignant disorder; however, as no additional index is provided, the reader may have some difficulty in finding 'cholangiocarcinoma and gallbladder cancer' under B (biliary tract cancer), or 'hairy cell leukemia' under L (leukemia). Even more confusingly, myeloproliferative diseases are not discussed together; instead, chronic myeloid leukemia is listed under L (leukemia) whereas polycythemia vera and essential thrombocytopenia are included in section III, which discusses selected hematologic diseases. The structure of this section in particular is somewhat confusing. In addition to frequent and rarer coagulation diseases, myelodysplastic syndromes are discussed separately from myeloid leukemias, despite the fact that these preleukemic diseases frequently transform into overt leukemia.
This is a preview of subscription content, access via your institution
